SERGIO MEJIA: Open Payments
NPI 1932127214 · HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$983 in 8 payments from 6 companies in 2025. Trend: 2023 $889 · 2024 $369 · 2025 $983
Food & beverage: $983
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $249 |
| Otsuka America Pharmaceutical, Inc. | 2 | $247 |
| Neurocrine BioSciences, Inc. | 1 | $128 |
| E.R. Squibb & Sons, L.L.C. | 1 | $125 |
| Alkermes, Inc. | 1 | $122 |
| Axsome Therapeutics, Inc. | 1 | $112 |
Products named: CAPLYTA, REXULTI, INGREZZA, COBENFY, LYBALVI, Auvelity.
Industry payments across CT — which companies pay providers there.
